×
  • My Account
  • About
  • Omnipresent
  • Events
  • Work for us
  • Contact
  • Team Members

Browse

  • Journals
  • Media
  • Careers
  • Gold
  • Education
  • Covid-19
  • Journals
  • Media
  • Careers
  • Gold
  • Education
  • Covid-19
  • More
  • Login / Register
  • Journals
  • Media
  • Careers
  • Gold
  • Education
  • Covid-19
  • Login / Register

Login to continue

Members

Forgotten your password?

Create Account

Create your own personal healthcare feed, full of the latest content from across our divisions.

Register

You must accept all conditions before being able to view the post
Continue
Logo
Personalise Content

Omnipresent - Video

Filter By Therapeutic Area

Cardiology
Reproductive Health
Oncology
Innovations
Respiratory
Allergy & Immunology
Gastroenterology
Urology
Neurology
Diabetes
Nephrology
Dermatology
Hematology
Hepatology
Interventional Cardiology
Rheumatology
Other
Pharma
Microbiology & Infectious Diseases
Radiology

Filter By Content Type

Webinars
Blog
Interviews
News
Press Release
Video

Treatment and outcome of CML patients from the EUTOS population-based registry

26 Jun 2015
Hematology

Venetoclax (ABT-199/GDC-0199) plus rituximab shows promise in relapsed/refractory CLL

26 Jun 2015
Hematology

Adding elotuzumab to standard treatment for myeloma reduced disease progression

26 Jun 2015
Hematology

Phase 3 CheckMate 067 trial of nivolumab in previously untreated advanced melanoma

26 Jun 2015
Oncology

Whole Brain Radiation Therapy is More Harmful Than Beneficial for Small Brain Metastases

26 Jun 2015
Oncology

Elective Neck Dissection Improved Survival in Early Node-Negative Oral Cancer

26 Jun 2015
Oncology

Improved Cancer Treatments Linked to Reduced Late Mortality in Childhood Cancer Survivors

26 Jun 2015
Oncology

Combined Nivolumab and Ipilimumab or Monotherapy Shown Promise in Untreated Melanoma

26 Jun 2015
Oncology

Novel JAK Inhibitor Pacritinib Proves Effective for Easing Symptoms of Myelofibrosis

26 Jun 2015
Oncology

Obinutuzumab Doubles Remission Duration in Relapsed, Indolent Non-Hodgkin Lymphoma

26 Jun 2015
Oncology

Daratumumab Shows Promise in Heavily Treatment-Resistant Multiple Myeloma

26 Jun 2015
Oncology

New Ibrutinib Combination Regimen Shows Substantial Benefits in Relapsed CLL

26 Jun 2015
Oncology

Dr A. Erdem Canda Chairs a Discussion on the Trends and Developments in the Field of Endourology

25 Jun 2015
Nephrology

An Interview with Dr. Abolfazl Hosseni at the 11th National Endourology Congress, Discussing the Developing Treatment in Bladder Cancer

25 Jun 2015
Urology

An Interview with Dr. Abhay Rane at the 11th National Endourology Congress, Discussing the Key Points of the Upcoming World Congess of Endourology

25 Jun 2015
Urology

An Interview with Dr. John W. Davis at the 11th National Endourology Congress, Discussing the Key Points from the Congress

25 Jun 2015
Urology

An Interview with Dr. Kevin C. Zorn at the 11th National Endourology Congress, Discussing Developments within the Field

25 Jun 2015
Urology

Nivolumab Shows Highly Promising Activity in Advanced Liver Cancer in Early-Stage Trial

02 Jun 2015
Urology

Genomic Marker Predicts Anti-PD-1 Response in Several Cancers

02 Jun 2015
Oncology

Nivolumab Extends Survival for Patients With the Most Common Lung Cancer

02 Jun 2015
Oncology

An introduction to ASCO 2015 by the 2014-15 president, Peter Paul Yu, MD, FACP, FASCO

02 Jun 2015
Oncology

PARP inhibitors and the EMBRACA study of talazoparib in BRCA-related metastatic breast cancer

21 May 2015
Oncology

The mechanisms of BRCA-related breast cancer and molecular profiling

21 May 2015
Oncology

Current research into treatments for BRCA-related breast cancer and the phase 3 EMBRACA trial

21 May 2015
Oncology

The role of BRCA and PARP in DNA repair and BRCA-related breast cancer

21 May 2015
Oncology

The phase 3 EMBRACA study of talazoparib in BRCA-related metastatic breast cancer

21 May 2015
Oncology

BRCA-related breast cancer: the implications of genetic testing and potential management options

12 May 2015
Oncology

Dr Keith Stewart chairs a discussion on early treatment and novel therapies for multiple myeloma

12 May 2015
Oncology
  • ←
  • 1
  • 2
  • 3
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • →
  • About us
  • Work for us
  • Omnipresent
  • Register
  • My Account
  • Contact
Copyright © 2021 European Medical Group LTD. All rights reserved. European Medical Group is for informational purposes and should not be considered medical advice, diagnosis or treatment recommendation.

Ts & Cs | Privacy Policy

Website by vercossa
UKAS ISO 9001

Proud to be ISO9001 Certified.

The ISO 9001 standard is an internationally recognised standard that is based on a number of quality management principles including a strong customer focus, the management of process change, effective methods of reducing non- compliance, and the continual improvement in the quality of our services.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.

Accept